98%
921
2 minutes
20
The COVID-19 pandemic, which has already claimed millions of lives, continues to pose a serious threat to human health, requiring the development of new effective drugs. Non-structural proteins of SARS-CoV-2 play an important role in viral replication and infection. Among them, NSP16 (non-structured protein 16) and its cofactor NSP10 (non-structured protein 10) perform C2'-O methylation at the 5' end of the viral RNA, which promotes efficient virus replication. Therefore, the NSP16-NSP10 complex becomes an attractive target for drug development. Using a multi-step virtual screening protocol which includes Lipinski's rule, docking, steered molecular dynamics and umbrella sampling, we searched for potential inhibitors from the PubChem and anti-HIV databases. It has been shown that CID 135566620 compound from PubChem is the best candidate with an inhibition constant in the sub-μM range. The Van der Waals interaction was found to be more important than the electrostatic interaction in the binding affinity of this compound to NSP16-NSP10. Further and studies are needed to test the activity of the identified compound against COVID-19.Communicated by Ramaswamy H. Sarma.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/07391102.2022.2114941 | DOI Listing |
Cell Rep
May 2025
MOE Key Laboratory for Cellular Dynamics and Hefei National Research Center for Interdisciplinary Sciences at the Microscale, Hefei 230027, China; School of Life Sciences, University of Science and Technology of China, Hefei 230027, China. Electronic address:
Mitotic chromosomes oscillate between the spindle poles upon the establishment of bi-orientation, which is essential for chromosome alignment and subsequent synchronous segregation. However, the molecular mechanisms underlying the oscillatory movement remain unclear. Recent studies revealed that phase separation of the end-binding protein 1 (EB1) is essential for eukaryotic cell division.
View Article and Find Full Text PDFWorld J Urol
October 2024
Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
PLoS Genet
May 2024
School of Biosciences and Bioengineering, Indian Institute of Technology, Mandi, India.
Ataxin-2 (ATXN2) is a gene implicated in spinocerebellar ataxia type II (SCA2), amyotrophic lateral sclerosis (ALS) and Parkinsonism. The encoded protein is a therapeutic target for ALS and related conditions. ATXN2 (or Atx2 in insects) can function in translational activation, translational repression, mRNA stability and in the assembly of mRNP-granules, a process mediated by intrinsically disordered regions (IDRs).
View Article and Find Full Text PDFBiochim Biophys Acta Biomembr
August 2024
Department of Chemistry, Indian Institute of Technology, Guwahati, Guwahati, India. Electronic address:
Short systemic half- life of Antimicrobial Peptides (AMP) is one of the major bottlenecks that limits their successful commercialization as therapeutics. In this work, we have designed analogs of the natural AMP Jelleine, obtained from royal jelly of apis mellifera. Among the designed peptides, J3 and J4 were the most potent with broad spectrum activities against a varied class of ESKAPE pathogens and fungus C.
View Article and Find Full Text PDFBiomolecules
March 2024
Department of Molecular Biology and Genetics, Democritus University of Thrace, Dragana University Campus, 68100 Alexandroupolis, Evros, Greece.